Home » Topics » Regulatory » Health Canada

Health Canada
RSS

Trisenox now available in Canada

Nov. 14, 2013

Canadian approval for Eylea in wet AMD

Nov. 14, 2013

Health Canada approves Opsumit for pulmonary arterial hypertension

Nov. 14, 2013

Health Canada approves Giotrif

Nov. 8, 2013

Health Canada approves Stivarga for gastrointestinal stromal tumors

Oct. 21, 2013

Jublia approved in Canada for the treatment of onychomycosis

Oct. 4, 2013

Bayer receives Canadian approval for riociguat in thromboembolic pulmonary hypertension

Sep. 26, 2013

Health Canada approves Roche's Erivedge for advanced basal cell carcinoma

Aug. 28, 2013

Jetrea approved for symptomatic vitreomacular adhesion in Canada

Aug. 19, 2013

Health Canada approves two GSK drugs for metastatic melanoma

July 25, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...